Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy

1 Oct 1998

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to DNA Repair Mechanisms
Share to Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 9861196
DOI: 10.1016/s0305-7372(98)90056-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapyPMID 9861196Read ↗

Platinum-Intercalator Conjugates: From DNA-Targeted Cisplatin Derivatives to Adenine Binding Complexes as Potential Modulators of Gene RegulationSemantic proximity Read ↗

PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outsSemantic proximity Read ↗

Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell linesSemantic proximity Read ↗

Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapySemantic proximity Read ↗

DNA Adducts in Cancer ChemotherapySemantic proximity Read ↗

The DNA damage response and cancer therapySemantic proximity Read ↗

Nucleotide excision repair, oxidative damage, DNA sequence polymorphisms, and cancer treatment.Semantic proximity Read ↗

DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategiesSemantic proximity Read ↗

Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer TherapySemantic proximity Read ↗

DNA damaging agents in ovarian cancerSemantic proximity Read ↗

Novel Approaches Towards Development of Non-Classical Platinum-Based Antineoplastic Agents: Design of Platinum Complexes Characterized by an Alternative DNA-Binding Pattern and/or Tumor-Targeted CytotoxicitySemantic proximity Read ↗

Cisplatin Is a DNA-Damaging Antitumour Compound Triggering Multifactorial Biochemical Responses in Cancer Cells: Importance of Apoptotic PathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.